Floatz logo

Therapeutic Asset Ratings

8,400 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tak-228
Lung Cancer
M.D. Anderson Cancer CenterP1/2B (57)
Tinengotinib
Triple-Negative Breast Carcinoma
TransThera Sciences (Nanjing), Inc.P1/2B (57)
Tislelizumab
Gastroesophageal Junction Adenocarcinoma
BeOne MedicinesP1/2B (57)
TRASTUZUMAB
Cervical Cancer
Ascendis Pharma Oncology Division A/SP1/2B (57)
TRASTUZUMAB
Metastatic Malignant Neoplasm
Seoul National University Bundang HospitalP1/2B (57)
TRASTUZUMAB
Small Cell Lung Carcinoma
Ascendis Pharma Oncology Division A/SP1/2B (57)
Venetoclax
Aggressive B-Cell Non-Hodgkin Lymphoma
Prelude TherapeuticsP1/2B (57)
Venetoclax
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Jonsson Comprehensive Cancer CenterP1/2B (57)
Venetoclax
Hematopoietic And Lymphoid System Neoplasm
Jacqueline Garcia, MDP1/2B (57)
Venetoclax
Myelodysplastic/Myeloproliferative Neoplasm
Prelude TherapeuticsP1/2B (57)
(+)-VINCRISTINE
Esophageal SCC
Neonc Technologies, Inc.P1/2B (57)
(+)-VINCRISTINE
Recurrent Lymphoepithelioma of the Nasopharynx
National Cancer Institute (NCI)P1/2B (57)
(+)-VINCRISTINE
Recurrent Squamous Cell Carcinoma of the Nasopharynx
AIDS Malignancy ConsortiumP1/2B (57)
VINCRISTINE SULFATE
Mature B-Cell Malignancies
BeOne MedicinesP1/2B (57)
Vinorelbine
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer CenterP1/2B (57)
Vinorelbine
Sarcoma
OHSU Knight Cancer InstituteP1/2B (57)
Vorinostat
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
OHSU Knight Cancer InstituteP1/2B (57)
vx-970
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1/2B (57)
Wve-006
Alpha 1-Antitrypsin Deficiency
Wave Life Sciences USA, Inc.P1/2B (57)
Zanubrutinib
Neoplasm Of Mature B-Cells
BeOne MedicinesP1/2B (57)
zsp1603
Idiopathic Pulmonary Fibrosis
Guangdong Raynovent Biotech Co., LtdP1/2B (57)
CARMUSTINE
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical CenterP1/2B (56)
cc-5013
Richter Transformation
M.D. Anderson Cancer CenterP1/2B (56)
cd19/cd20 dual-car-t cells
B-Cell Non-Hodgkin Lymphoma
Beijing Tsinghua Chang Gung HospitalP1/2B (56)
Cediranib
AIDS-Related Plasmablastic Lymphoma
City of Hope Medical CenterP1/2B (56)
Showing 176 to 200 of 8,400 assets
PreviousPage 8 of 336Next